Zurich Cantonal Bank’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$372K Sell
4,486
-90
-2% -$7.47K ﹤0.01% 1842
2025
Q1
$386K Sell
4,576
-19,021
-81% -$1.61M ﹤0.01% 1753
2024
Q4
$2.12M Sell
23,597
-276
-1% -$24.8K 0.01% 823
2024
Q3
$2.37M Buy
23,873
+148
+0.6% +$14.7K 0.01% 752
2024
Q2
$2.19M Sell
23,725
-1,532
-6% -$141K 0.01% 735
2024
Q1
$2.4M Buy
+25,257
New +$2.4M 0.01% 706
2023
Q3
Sell
-987
Closed -$81.5K 2801
2023
Q2
$81.5K Sell
987
-9,373
-90% -$774K ﹤0.01% 2434
2023
Q1
$774K Buy
10,360
+235
+2% +$17.6K ﹤0.01% 1027
2022
Q4
$833K Sell
10,125
-129
-1% -$10.6K ﹤0.01% 960
2022
Q3
$808K Buy
10,254
+176
+2% +$13.9K ﹤0.01% 922
2022
Q2
$754K Sell
10,078
-14,297
-59% -$1.07M ﹤0.01% 982
2022
Q1
$2.21M Buy
24,375
+326
+1% +$29.5K 0.01% 700
2021
Q4
$2.73M Buy
24,049
+764
+3% +$86.6K 0.01% 670
2021
Q3
$2.92M Buy
23,285
+273
+1% +$34.3K 0.02% 660
2021
Q2
$3.12M Buy
23,012
+38
+0.2% +$5.16K 0.02% 614
2021
Q1
$2.99M Buy
22,974
+1,137
+5% +$148K 0.02% 609
2020
Q4
$3.15M Buy
21,837
+2,399
+12% +$346K 0.02% 616
2020
Q3
$2.17M Buy
19,438
+659
+4% +$73.6K 0.02% 674
2020
Q2
$2.07M Buy
18,779
+1,814
+11% +$200K 0.02% 635
2020
Q1
$1.33M Buy
16,965
+8,230
+94% +$644K 0.01% 682
2019
Q4
$827K Buy
8,735
+200
+2% +$18.9K 0.01% 842
2019
Q3
$652K Hold
8,535
0.01% 859
2019
Q2
$749K Buy
8,535
+1,900
+29% +$167K 0.01% 854
2019
Q1
$601K Buy
6,635
+900
+16% +$81.5K 0.01% 852
2018
Q4
$411K Buy
5,735
+700
+14% +$50.2K ﹤0.01% 931
2018
Q3
$483K Buy
5,035
+635
+14% +$60.9K ﹤0.01% 938
2018
Q2
$419K Hold
4,400
﹤0.01% 946
2018
Q1
$386K Buy
+4,400
New +$386K ﹤0.01% 925